MedTrace Logo

Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment

NCT01471899 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2021-02-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drugs in the treatment of patients diagnosed with moderate to severe back pain treatment.

Conditions

Interventions

DRUG

Ketorolac Tromethamine

10 drops each 8 hours for 4 days.

DRUG

Naproxen

2 tablets every 8 hours for 4 days

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Principal Investigators

  • Pérola Plaper, MD · Instituto do Coracao

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-12-31
Completion
2014-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01471899 on ClinicalTrials.gov